The most important September 11 story this morning is not another retrospective. It is a piece of unfinished public-health work. Roughly 25,000 children lived or attended school near the World Trade Center on September 11, 2001, including babies and children who were still in utero. Many were exposed to the dense cloud of pulverized building material, combustion products and other contaminants that spread through lower Manhattan and parts of Brooklyn.
Adults who worked at the site, particularly firefighters and other first responders, became the center of large federal monitoring programs. Those efforts eventually documented elevated rates of respiratory disease, cancers and other conditions. Children, however, were never enrolled in a similarly comprehensive national cohort.
Congress approved funding in 2022 to close that gap. The Centers for Disease Control and Prevention is now moving toward a World Trade Center Youth Research Coordinating Center, with as much as $50 million available. The plan is to identify and follow people who were under 21, or in utero, and living or going to school in lower Manhattan or affected areas of Brooklyn on and after the attacks.
The delay matters scientifically. Childhood exposure can affect different organs and developmental stages than adult exposure, and some diseases do not appear for decades. A carefully built comparison group can help separate conditions linked to the disaster from conditions that would have occurred anyway.
The broader lesson is about disaster design. Emergency response naturally focuses on the immediate crisis and the most visibly exposed adults. The 9/11 experience shows why major incidents also need a long-horizon health plan from day one, including children and other groups whose risks may not become obvious until years later.
On the 25th anniversary of September 11, a major gap in the medical record is finally being addressed: children exposed to the World Trade Center disaster will be studied as a distinct long-term cohort. The CDC↗-backed effort is expected to launch by July 2027 with up to $50 million in funding.